Talus Bio, an EVS WIN Grad, Launches Ptarmigan-1, the First Structure-Free AI Model for Proteome-Wide Drug Discovery

Talus Bioscience, Inc., an AI-native therapeutics company and LSW EVS WIN grad, released Ptarmigan-1, a solution powered by the company’s MARMOT platform, which it describes as a first-of-its-kind structure-free AI model that accurately predicts small molecule binding sites across the entire human proteome, including proteins that are too unstructured for traditional 3D modeling tools to resolve. Access to Ptarmigan-1 is now available through a public portal.